Recent Finacing
Recent Raise
Advanced Cancer Therapeutics licenses oncology discoveries from the University of Louisville and manages development, manufacture, and commercialization of small-molecule PFKFB3/Choline Kinase inhibitors and a PU27 DNA oligonucleotide.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
